BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 8073808)

  • 1. Methotrexate and cyclosporin combined therapy in severe psoriatic arthritis. A pilot study.
    Mazzanti G; Coloni L; De Sabbata G; Paladini G
    Acta Derm Venereol Suppl (Stockh); 1994; 186():116-7. PubMed ID: 8073808
    [No Abstract]   [Full Text] [Related]  

  • 2. Short-term "cyclosporin A" therapy for psoriatic arthritis.
    Riccieri V; Sili Scavalli A; Spadaro A; Bracci M; Taccari E; Zoppini A
    Acta Derm Venereol Suppl (Stockh); 1994; 186():94-5. PubMed ID: 8073853
    [No Abstract]   [Full Text] [Related]  

  • 3. Fluctuation of circulating plasmacytoid dendritic cells in a patient with psoriatic arthritis.
    Sugita K; Hino R; Ogata M; Kabashima K; Tokura Y
    J Eur Acad Dermatol Venereol; 2008 Nov; 22(11):1365-6. PubMed ID: 19018884
    [No Abstract]   [Full Text] [Related]  

  • 4. Deactivation of endothelium and reduction in angiogenesis in psoriatic skin and synovium by low dose infliximab therapy in combination with stable methotrexate therapy: a prospective single-centre study.
    Goedkoop AY; Kraan MC; Picavet DI; de Rie MA; Teunissen MB; Bos JD; Tak PP
    Arthritis Res Ther; 2004; 6(4):R326-34. PubMed ID: 15225368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The treatment of severe psoriatic arthritis with methotrexate in a weekly "mini-pulse" dosage plan].
    Parasca I; Boloşiu HD; Rus V; Duţu A
    Med Interna; 1991; 43(1-2):150-3. PubMed ID: 1670121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of psoriatic arthritis with etanercept, methotrexate, and cyclosporin A.
    Gül U; Gönül M; Kiliç A; Erdem R; Cakmak SK; Gündüz H
    Clin Ther; 2006 Feb; 28(2):251-4. PubMed ID: 16678646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination treatment with methotrexate, cyclosporine, and intraarticular betamethasone compared with methotrexate and intraarticular betamethasone in early active rheumatoid arthritis: an investigator-initiated, multicenter, randomized, double-blind, parallel-group, placebo-controlled study.
    Hetland ML; Stengaard-Pedersen K; Junker P; Lottenburger T; Ellingsen T; Andersen LS; Hansen I; Skjødt H; Pedersen JK; Lauridsen UB; Svendsen A; Tarp U; Pødenphant J; Hansen G; Lindegaard H; de Carvalho A; Østergaard M; Hørslev-Petersen K;
    Arthritis Rheum; 2006 May; 54(5):1401-9. PubMed ID: 16645967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Psoriatic arthritis: combined treatment with prospidin and methotrexate].
    Simonova OV; Nemtsov BF
    Ter Arkh; 2005; 77(8):60-4. PubMed ID: 16206608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long term infliximab treatment for severe psoriatic arthritis: evidence of sustained clinical and radiographic response.
    Rinaldi F; Provenzano G; Termini A; Spinello M; La Seta F
    Ann Rheum Dis; 2005 Sep; 64(9):1375-6. PubMed ID: 16100346
    [No Abstract]   [Full Text] [Related]  

  • 10. Psoriatic arthritis treated with cyclosporin A.
    Kokelj F; Lavaroni G; Stinco G
    Allerg Immunol (Paris); 1992 Dec; 24(10):393-4. PubMed ID: 1288546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Life-table analysis of etanercept with or without methotrexate in patients with psoriatic arthritis.
    Spadaro A; Ceccarelli F; Scrivo R; Valesini G
    Ann Rheum Dis; 2008 Nov; 67(11):1650-1. PubMed ID: 18854519
    [No Abstract]   [Full Text] [Related]  

  • 12. Caffeine consumption and methotrexate dosing requirement in psoriasis and psoriatic arthritis.
    Swanson DL; Barnes SA; Mengden Koon SJ; el-Azhary RA
    Int J Dermatol; 2007 Feb; 46(2):157-9. PubMed ID: 17269967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multidisciplinary focus on methotrexate in psoriatic disesase.
    Marchesoni A; Ricci M; Moggio E; Brazzelli V; Borroni G
    J Rheumatol Suppl; 2009 Aug; 83():56-8. PubMed ID: 19661543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psoriatic arthritis. New types, new treatments.
    Ruzicka T
    Arch Dermatol; 1996 Feb; 132(2):215-9. PubMed ID: 8629831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomised, double blind, placebo controlled, multicentre trial of combination therapy with methotrexate plus ciclosporin in patients with active psoriatic arthritis.
    Fraser AD; van Kuijk AW; Westhovens R; Karim Z; Wakefield R; Gerards AH; Landewé R; Steinfeld SD; Emery P; Dijkmans BA; Veale DJ
    Ann Rheum Dis; 2005 Jun; 64(6):859-64. PubMed ID: 15528283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effective etanercept treatment for psoriatic arthritis complicating concomitant human immunodeficiency virus and hepatitis C virus infection.
    Linardaki G; Katsarou O; Ioannidou P; Karafoulidou A; Boki K
    J Rheumatol; 2007 Jun; 34(6):1353-5. PubMed ID: 17552060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Etanercept therapy improves symptoms and allows tapering of other medications in children and adolescents with moderate to severe psoriasis.
    Kress DW
    J Am Acad Dermatol; 2006 Mar; 54(3 Suppl 2):S126-8. PubMed ID: 16488325
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment with cyclosporin in patients with psoriatic arthritis: results of clinical assessment.
    Raffayová H; Rovenský J; Mális F
    Int J Clin Pharmacol Res; 2000; 20(1-2):1-11. PubMed ID: 11146896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Self-injection of gold and methotrexate.
    Arthur V; Jubb R; Homer D
    J Rheumatol; 2001 Jan; 28(1):212. PubMed ID: 11196528
    [No Abstract]   [Full Text] [Related]  

  • 20. Methotrexate: new indication. Psoriatic arthritis: approved at last.
    Prescrire Int; 2007 Oct; 16(91):182. PubMed ID: 17926820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.